Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
Prostate Disease

Volume 28, Issue 5 (Sep 2026)
177Lu-PSMA for prostate cancer: progress, challenges and future perspectives
Xi, Zhen*; Ji, Shi-Yu*; Zhang, Yu; Sun, Ming-Hui; Jia, Gao-Zhen; Jiang, Qi
Asian J Androl 28: 467-477; 10.4103/aja2025103
Abstract |Full Text | PDF

Real-world effectiveness and safety of radium-223 therapy in castration-resistant prostate cancer with bone metastases
Wang, Hong-Kai1,2,3,*; Hang, Zhen1,2,3,*; Liu, Chang2,4; Dai, Bo1,2,3; Zhu, Yao1,2,3; Qin, Xiao-Jian1,2,3; Lin, Guo-Wen1,2,3; Deng, Yan-Bo5; Jiang, He-Xun5; Wang, Ya5; Song, Shao-Li2,4; Ye, Ding-Wei1,2,3
Asian J Androl 28: 561-567; 10.4103/aja202598
Abstract |Full Text | PDF

Predicting the upgrading of the International Society of Urological Pathology Grade Group in nonclinically significant prostate cancer: a multicenter observational study
Zhou, Ling1; Li, Shi-Yan1; Wang, Zhang-Yun2; Liu, Yu-Yu1; Chen, Chao3; Yu, Hong4
Asian J Androl 28: 660-666; 10.4103/aja2025115
Abstract |Full Text | PDF

Volume 28, Issue 4 (Jul 2026)
Multidimensional explanations and future perspectives on the limited efficacy of immunotherapy in prostate cancer
Fan, Shan-Shan1; Chen, Yi-Min2,3; Chen, Wen-Da2,3; Sun, Zheng-Hua1; Yin, Jian1; Xie, Mei1; Wu, Pu1,2,3
Asian J Androl 28: 345-358; 10.4103/aja202591
Abstract |Full Text | PDF

Volume 28, Issue 3 (May 2026)
The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer
Wang, Qian*; Zhang, Ming*; Zhu, Qi-Yu; Zeng, Hong; Dai, Jin-Dong; Huang, Ke; Wan, Si-Cheng; Shi, Yi-Fu; Zhang, Xing-Ming; Zeng, Hao; Shen, Peng-Fei
Asian J Androl 28: 304-309; 10.4103/aja202520
Abstract |Full Text | PDF

Seasonal Gleason scores: compelling observations amid methodological complexity
Islam, Raeesa; Golombos, David M; Ghodoussipour, Saum
Asian J Androl 28: 343-343; 10.4103/aja202579
Full Text | PDF

Volume 28, Issue 2 (Mar 2026)
The importance of the season of biopsy on the Gleason score on biopsy: does exposure to sunshine have an influence?
Delouya, Guila; Taussky, Daniel
Asian J Androl 28: 162-165; 10.4103/aja202536
Abstract |Full Text | PDF

Inhibition of 5αR2 promotes postoperative wound repair in BPH patients after TURP by alleviating fibrosis and inflammation
Zheng, Cheng-Hao*; Wang, Wen-Hao*; Ji, Shi-Yu; Jing, Yi-Feng; Han, Bang-Min; Xia, Shu-Jie; Wang, Xing-Jie
Asian J Androl 28: 187-195; 10.4103/aja202561
Abstract |Full Text | PDF

Volume 28, Issue 1 (Jan 2026)
Inhibition of the PI3K/AKT signaling pathway blocks the oncogenic activity of TRIM26 in prostate cancer cells
Zhong, Yue-Ya1,*; Zhang, Li-Huan1,*; Zhou, Xin-Ye1; Zhou, Xiu-Min2; He, Yuan-Ming1; Mao, Xin-Liang1; Xu, Xiao-Feng3,4
Asian J Androl 28: 89-95; 10.4103/aja202526
Abstract |Full Text | PDF

From non-clinically significant to clinically significant prostate cancer: identifying predictors of discrepancy from biopsy to radical prostatectomy
Zhang, Yong-Qing1,2,3,*; Liu, Zheng1,2,3,*; Ye, Bi-Ran1,2; Liu, Shi-Wei1,2,3; Wan, Fang-Ning1,2,3; Hong, Zhe1,2,3; Xu, Hua1,2,3; Dai, Bo1,2,3
Asian J Androl 28: 103-108; 10.4103/aja202547
Abstract |Full Text | PDF

[首页] [前一页]第 页 [后一页] [尾页]  共有70页,10条记录

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.